top of page
Rinnit logo – modern health products and health news

Immunophenotyping: How It Identifies Blood Cells to Diagnose Leukemia and Lymphoma

7 days ago
4 min read

Updated: 2 days ago

Written and medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: November 2026 · How we review

Quick Answer

Immunophenotyping is a lab test that identifies the types of white blood cells in a sample by the markers, called antigens, on their surface. It's most often done with flow cytometry on blood or bone marrow. Providers use it mainly to diagnose and classify leukemia and lymphoma and to track how well treatment is working.

What the research says

  • Flow cytometry is central to diagnosing blood cancers: a review in Blood describes how flow cytometric immunophenotyping, as part of the World Health Organization's multiparameter approach, is used to diagnose and classify blood cancers and guide other testing, following international consensus indications (Craig FE et al., Blood, 2008) [2]

  • Clearing leftover leukemia cells predicts better outcomes: a meta-analysis of 39 studies with 13,637 patients found that reaching minimal residual disease (MRD) negativity, often measured with flow cytometry, was linked to about a 77% lower risk of relapse or death in children and 72% in adults with acute lymphoblastic leukemia (Berry DA et al., JAMA Oncol, 2017) [3]

Key takeaways

  • Immunophenotyping identifies cells by the markers on their surface.

  • It's most often done with flow cytometry.

  • Samples are usually blood or bone marrow.

  • It helps diagnose and classify leukemia and lymphoma.

  • It can also detect small numbers of leftover cancer cells after treatment.

What is immunophenotyping?

Every type of white blood cell carries a typical set of surface proteins, often named with CD (cluster of differentiation) numbers. Cancer cells often show an unusual pattern. In immunophenotyping, the lab adds antibodies that stick to specific markers, then measures which cells light up. This shows what kinds of cells are present and whether a group of abnormal cells all came from the same source. Sources: [1, 2]

How it works

Three steps of immunophenotyping: tag cells with antibody dyes, pass cells through a laser, read the marker pattern

Flow cytometry reads thousands of cells per second.

  1. The sample is mixed with antibodies tagged with fluorescent dyes.

  2. In flow cytometry, cells flow one by one past a laser, and detectors record which dyes each cell carries.

  3. A specialist reads the pattern of markers to identify cell types. Sources: [1, 2]

In immunohistochemistry, the antibodies are applied to a thin slice of tissue, such as a lymph node biopsy, and viewed under a microscope. Sources: [1]

Samples used

Samples for immunophenotyping: blood, bone marrow, spinal fluid, abdominal fluid, lymph node tissue

The sample depends on where abnormal cells are suspected.

  • Blood: a routine draw from a vein.

  • Bone marrow: collected with a bone marrow biopsy, usually from the hip bone.

  • Spinal fluid: collected with a lumbar puncture if cancer may have reached the nervous system.

  • Abdominal fluid or tissue: from a needle sample or biopsy. Sources: [1]

Why it's done

Uses of immunophenotyping: diagnose leukemia, classify lymphoma, guide treatment, monitor residual disease

The test supports diagnosis, treatment choice and follow-up.

Understanding results

There isn't one standard procedure or normal value. A hematopathologist reports which cell types were found and whether there's an abnormal group of cells with a particular marker pattern. Results are read together with your blood count, bone marrow findings, genetic tests and symptoms. Sources: [1, 2]

Conclusion

Immunophenotyping helps providers see exactly which cells are present in a sample. It's a key tool for diagnosing and classifying blood cancers and for checking whether treatment has cleared the disease.

Keep learning: read about flow cytometry and leukemia.

Frequently asked questions

What does immunophenotyping test for?

The types of white blood cells in a sample, based on surface markers.

Is immunophenotyping the same as flow cytometry?

Flow cytometry is the most common method used to do it.

What samples are used?

Usually blood or bone marrow; sometimes spinal fluid, abdominal fluid or tissue.

Why would I need this test?

Most often to diagnose or classify leukemia or lymphoma.

Is the test painful?

A blood draw is quick; a bone marrow biopsy causes more discomfort.

What are CD markers?

Surface proteins labeled with numbers that identify cell types.

Can it detect cancer after treatment?

Yes. It can find minimal residual disease.

Is there a normal result?

There's no single normal value; a specialist interprets the pattern.

How long do results take?

It varies by lab and test, often several days.

What other tests are done with it?

Blood counts, bone marrow exams and genetic tests.

Related Reading

Immunostaining: How Labeled Antibodies Help Diagnose Cancer and Other Diseases explains the antibody staining methods pathologists use to pinpoint a diagnosis.

Understanding Leukemia: Types, Symptoms, and Modern Management the blood cancers this test helps classify.

References

  1. Cleveland Clinic. What Is Immunophenotyping? Purpose, Testing & Results. Cleveland Clinic. Last updated July 1, 2024. https://my.clevelandclinic.org/health/diagnostics/immunophenotyping

  2. Craig FE, Foon KA. Flow cytometric immunophenotyping for hematologic neoplasms. Blood. 2008;111(8):3941-3967. PMID 18198345. https://doi.org/10.1182/blood-2007-11-120535

  3. Berry DA, Zhou S, Higley H, et al. Association of minimal residual disease with clinical outcome in pediatric and adult acute lymphoblastic leukemia: a meta-analysis. JAMA Oncol. 2017;3(7):e170580. PMID 28494052. https://doi.org/10.1001/jamaoncol.2017.0580

Medical disclaimer

This article is for general education only and does not replace advice from a qualified healthcare professional. Talk to your doctor about your own diagnosis and treatment, and seek emergency care right away for severe or sudden symptoms.

Comments


bottom of page